🎧 Podcast

Helen McShane, Young Lives vs Cancer and Zoe Peden, Ananda on Mission-Driven Capital: When a 60-Year-Old Frontline Charity Becomes an…

What happens when a 60-year-old frontline charity decides not only to support families but also to invest in startups?

Mar 13

22:53

Dr Lilian Schwich, cylib on Europe’s Battery Recycling Gap

Europe’s climate transition is no longer only about emissions.

Mar 11

38:03

Ash Pournouri (Belong), Sundar Arvind (Mozart AI) & Daniel Waterhouse (Balderton Capital): AI Music, Control and the Next Creative Era

This special episode is an inside look at AI music from three very different vantage points: the builder, the investor, and the industry insider.

Mar 6

54:35

Jo Slota-Newson & Marc Sabas, Almanac Ventures: Systemic Deep Tech for Industrial Decarbonisation

Industrial systems are responsible for 75% of global emissions, yet only a quarter of climate-focused VC money flows into them.

Mar 5

16:35

Martin Schilling, Deep Tech Momentum: Why Europe’s Deep Tech Problem Isn’t Funding

Europe does not have a deep tech problem.

Mar 4

47:58

Theo Cesarini, Incard & Thomas Depuydt, Smartfin: Building the Financial OS for Digital-First Companies

Europe’s banking stack wasn’t built for high-growth digital operators.

Mar 2

21:39

This Week in European Tech with Dan Bowyer, Mads Jensen & Lomax Ward

Welcome back to another episode of Upside where Dan Bowyer, Mads Jensen of SuperSeed and Lomax Ward of Outsized Ventures go behind the headlines shaping…

Mar 2

59:21

Max Bray and Juliet Bailin, Kindred Capital VC: LP Conviction, $15B Funds & The Venture Barbell

What exactly are LPs buying when they allocate to venture today and do they still believe in it?

Feb 27

37:27

Sahil Patwa, Tenet: AI Rollups, Empathy-Driven Transformation, and Why Buying SMEs May Beat Selling SaaS

AI can already automate close to 50% of knowledge work.

Feb 27

18:39

Pedro Coelho, Biorce: From Personal Loss to a $52M Series A and the One-Click Clinical Trial Vision

Clinical trials take, on average, 12 years and billions in capital before a drug reaches a pharmacy shelf.

Feb 26

19:05

Lubomila Jordanova, Plan A: Climate Isn’t “Over”

Climate isn’t “over.” But building in climate has entered a new chapter, defined by shifting regulation, politicized narratives, buyer confusion, and a…

Feb 25

35:16

Andy Lurling, Lumo Labs: Smart Capital from Eindhoven and Investing in AI for Health

In a market where “AI fund” can mean almost anything, Lumo Labs is unusually specific: digital deep tech, deployed early, and anchored in one of…

Feb 24

21:34

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts